THALLIUM PHARMACOKINETICS AND ITS MODIFICATION BY PRUSSIAN BLUE

被引:50
作者
RAUWS, AG [1 ]
机构
[1] NATL INST PUBL HLTH,LAB PHARMACOL,POB 1,BILTHOVEN,NETHERLANDS
关键词
D O I
10.1007/BF00500348
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:295 / 306
页数:12
相关论文
共 17 条
[1]  
Albers R.W., 1972, BASIC NEUROCHEMISTRY
[2]  
Altman P.L., 1961, FED AM SOC EXP BIOL
[3]   METABOLIC BEHAVIOUR OF COLLOIDAL FERRIHEXACYANOFERRATE(II) [J].
DVORAK, P ;
GUNTHER, M ;
ZORN, U ;
CATSCH, A .
NAUNYN-SCHMIEDEBERGS ARCHIV FUR PHARMAKOLOGIE, 1971, 269 (01) :48-&
[4]  
GEHRING PJ, 1964, J PHARMACOL EXP THER, V145, P215
[5]  
GLADTKE E, 1973, PHARMAKOKINETIK
[6]   FERRIC-CYANOFERRATE (2) - AN EFFECTIVE ANTIDOTE IN THALLIUM POISONING [J].
HEYDLAUF, H .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1969, 6 (03) :340-+
[7]  
KAMERBEEK HH, 1971, ACTA MED SCAND, V189, P149
[8]  
KAMERBEEK HH, 1971, ACTA MED SCAND, V189, P321
[9]  
LIE R., 1960, HEALTH PHYS, V2, P334, DOI 10.1097/00004032-195910000-00004
[10]  
LUND A, 1956, ACTA PHARMACOL TOX, V12, P251